Sequential brentuximab vedotin and AVD for older Hodgkin lymphoma patients: initial results from a phase 2 multicenter study.
Sequential brentuximab vedotin and AVD for older Hodgkin lymphoma patients: initial results from a phase 2 multicenter study.
Clin Adv Hematol Oncol. 2015 Aug;13(8 Suppl 9):8-9
Authors: Moskowitz CH
PMID: 26452082 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research